SUHAGRA 25
- Manufacturer:
- Cipla
- Active ingredient
- Sildenafil Citrate
- Dosage
- 25 mg
- Best before date
- Until 2026-2027
- Reception
- 1 hour before the act
- Time of action
- Up to 5-6 hours
- Daily dose
- 100 mg
- Compatibility with alcohol
- No
Available product types:
What is SUHAGRA 25?
The drug SUHAGRA 25 is a highly effective medicinal agent developed for the systemic therapy of erectile dysfunction of various degrees of severity in adult men. This medicinal product belongs to the pharmacological group of selective phosphodiesterase type 5 inhibitors, which regulate hemodynamics in the pelvic organs. The manufacturer of this pharmaceutical product is the world-renowned Indian company Cipla, which has established itself as a reliable developer of high-quality generic drugs in strict compliance with international GMP standards. The release form in the form of film-coated tablets ensures ease of use and stable absorption of the active component by the gastrointestinal tract.
The basis of the drug's effectiveness is an optimized dosage, which allows achieving a pronounced therapeutic result with minimal pharmacological load on the patient's body. Thanks to this, SUHAGRA 25 is positioned in clinical practice as a mild potency regulator, ideally suited for the initial stage of treatment or for continuous maintenance therapy. Sildenafil in the amount of 25 mg acts exclusively in the presence of natural sexual stimulation, which eliminates the risk of involuntary or uncoordinated erection. Each batch of products undergoes multi-level quality control, which guarantees compliance of bioequivalence with the original drug Viagra.
It should be borne in mind that the intensity of the pharmacological response may vary depending on the physical condition, age, and the presence of concomitant pathologies in the patient. Since the body's reaction to the stimulation of blood circulation is purely individual, before starting to use this agent, it is mandatory to undergo an examination and obtain a doctor's consultation. Self-treatment of sexual disorders can lead to undesirable consequences for the cardiovascular system. A qualified specialist will help assess the feasibility of using this particular concentration of the active substance and rule out the presence of hidden contraindications.
What is SUHAGRA 25 prescribed for?
The main clinical indication for the use of SUHAGRA 25 is erectile dysfunction, defined as the prolonged or recurrent inability of a man to achieve or maintain an erection sufficient for satisfactory sexual performance. The medicinal product effectively eliminates problems of a sexual nature that have both psychogenic origin (stress, anxiety, performance anxiety) and organic etiology (initial stages of vascular pathologies, consequences of certain diseases). Regular or periodic intake allows restoring the natural physiological response to sexual arousal and restoring self-confidence.
In addition, SUHAGRA 25 is often recommended for patients with increased sensitivity to sildenafil or elderly men, for whom standard doses of 50 mg or 100 mg are excessive. The use of a reduced dosage allows successfully compensating for vascular insufficiency of the cavernous bodies without creating an excessive load on the myocardium and arterial tree. The medication is also prescribed in cases where a mild form of disorder is observed, and only minimal pharmacological support of the body is required to achieve the necessary hardness of the penis.
The use of this agent helps improve the quality of sexual life, increase self-esteem, and harmonize partner relationships. All clinical effects are realized provided that sexual desire is preserved, since the drug is not a stimulant or libido protector in the direct sense. The selection of the optimal application scheme should be carried out on the basis of the patient's anamnesis. It should be remembered that the individual reaction of the body to therapy may differ, so a preliminary examination by a urologist or andrologist is an obligatory stage before starting courses.
Composition and active components of SUHAGRA 25
The main active component contained in SUHAGRA 25 is sildenafil citrate in an amount equivalent to 25 mg of pure sildenafil. This substance is a highly selective inhibitor of the enzyme phosphodiesterase type 5 (PDE-5), which is responsible for the breakdown of cyclic guanosine monophosphate (cGMP) in the cavernous bodies. During sexual arousal, a local release of nitric oxide occurs, which stimulates the synthesis of cGMP, relaxes the smooth muscles of the arteries, and provides a powerful flow of blood to the penis. By blocking PDE-5, sildenafil maintains a high concentration of cGMP, due to which a stable erection is achieved and maintained for a long time.
In addition to the active pharmacological component, the composition of the tablet includes carefully selected excipients that ensure its structural integrity, stability during storage, and optimal dissolution rate in the stomach. These include microcrystalline cellulose, anhydrous calcium hydrogen phosphate, croscarmellose sodium, magnesium stearate, and hypromellose. A special film coating protects the esophageal mucosa from irritation and promotes the uniform release of the active substance directly into the systemic circulation.
Dosage of SUHAGRA 25
For most adult patients, the dosage of SUHAGRA 25 is the starting therapeutic dose prescribed for the first use of sildenafil or in the presence of a predisposition to the development of adverse reactions. The drug is taken orally as needed, approximately 30–60 minutes before anticipated sexual activity. The maximum recommended frequency of administration is once a day, and exceeding this limit is prohibited to avoid overdose and the development of systemic complications. Depending on the achieved effect and tolerability, the doctor may decide to maintain this dosage or increase it.
Dose adjustment is required for certain categories of patients, in particular elderly people (over 65 years old), as well as people with moderate renal or hepatic impairment. For such men, the 25 mg dose is the most safe and clinically justified, as the elimination of drug metabolites from the body slows down in them. The duration of courses or frequency of administration is determined by the doctor individually on the basis of systematic monitoring of the patient's health indicators.
How to take SUHAGRA 25 correctly?
The SUHAGRA 25 tablet should be swallowed whole, without chewing or crushing, with a sufficient amount of ordinary drinking water. Taking the drug with a fatty, heavy meal may delay the onset of its action, as fats slow down the absorption of sildenafil in the gastrointestinal tract. To achieve the maximum and rapid effect, it is recommended to take the agent on an empty stomach or after a light meal. It must be taken into account that the action of the pharmacological agent lasts on average from 4 to 5 hours, providing a natural window for sexual intercourse.
Since this agent is used as needed, the concept of a "missed dose" does not apply to it. It is strictly forbidden to take a double dose to compensate if, for some reason, the expected effect seems insufficient. If in doubt about the effectiveness, it is necessary to consult a doctor rather than increase the number of tablets taken on your own. Before using the drug, you should make sure there are no individual contraindications and carefully read the instructions.
Side effects of SUHAGRA 25
Due to the low concentration of the active substance, SUHAGRA 25 is characterized by a high safety profile, but in rare cases, the development of undesirable reactions is possible. The most common side effects include mild headache, flushing of the face and upper body, light dizziness, and nasal congestion. Patients may also observe short-term digestive disorders (dyspepsia, nausea) or temporary vision changes, such as altered color perception (increased blue tint) or increased sensitivity to light.
Rarely, more pronounced systemic reactions may occur, including tachycardia, arterial hypotension or hypertension, muscle and back pain, and dry mouth. If, after taking the medication, chest pain, a prolonged and painful erection (priapism lasting more than 4 hours), or a sudden deterioration of vision or hearing occurs, you should immediately stop using the product and seek emergency medical assistance. All undesirable manifestations are usually reversible and disappear after the action of the active substance ceases.
Contraindications of SUHAGRA 25
An absolute contraindication to the use of SUHAGRA 25 is hypersensitivity or allergic reactions to sildenafil or any of the excipients of the drug. The agent is strictly prohibited to be taken simultaneously with nitric oxide donors, organic nitrates, or nitrites in any forms, as sildenafil enhances their hypotensive effect, which can lead to a critical drop in blood pressure. It is also contraindicated to prescribe to individuals for whom sexual activity is undesirable due to the presence of severe cardiovascular diseases (unstable angina, severe heart failure).
Other important contraindications include a recent myocardial infarction or stroke (within the last 6 months), severe hepatic impairment, pronounced arterial hypotension, as well as hereditary degenerative diseases of the retina (for example, retinitis pigmentosa). The drug is intended exclusively for men who have reached 18 years of age. The use of this agent by women, children, as well as during pregnancy and lactation is strictly prohibited, as safety and efficacy for these groups have not been studied.
Interaction of SUHAGRA 25 with other medicines and alcohol
Parallel administration of SUHAGRA 25 with other medicinal products requires increased caution and mandatory coordination with a pharmacologist or treating physician. Simultaneous use with alpha-blockers used for the treatment of arterial hypertension or prostatic hyperplasia may lead to orthostatic hypotension in some sensitive patients. Potent inhibitors of the CYP3A4 isoenzyme (such as ketoconazole, erythromycin, ritonavir) significantly slow down the metabolism of sildenafil, increasing its concentration in blood plasma, which requires dose adjustment.
It is categorically not recommended to combine the intake of the medication with the consumption of alcoholic beverages. Ethyl alcohol itself suppresses the function of the central nervous system and negatively affects erectile function, and in combination with sildenafil, it significantly increases the risk of side effects such as dizziness, fainting, and a sharp drop in blood pressure. Also, during therapy, one should refrain from consuming grapefruit juice, as it alters the pharmacokinetics of the active substance. The effect on reaction speed when driving vehicles is usually absent, but if dizziness occurs, one should refrain from driving.
Where to buy SUHAGRA 25 in Ukraine
You can buy SUHAGRA 25 in Ukraine in pharmacies or through specialized certified online platforms engaged in the distribution of pharmaceutical products. When purchasing, you should pay attention to the presence of appropriate markings, the integrity of the packaging, and expiration dates to avoid purchasing counterfeit goods. The drug is sold in original blisters that reliably protect the tablets from environmental influences. Delivery across Ukraine is carried out by logistics services in compliance with confidentiality conditions and temperature control.
Store SUHAGRA 25 in its original packaging in a dry, dark place out of reach of children at a temperature not exceeding 25 °C. Do not use the product after the expiration date printed on the pack. We remind you that this article is for informational purposes only. Before using the drug, be sure to consult a doctor, as your body's reaction may be individual, and a specialist will help ensure maximum safety and effectiveness of treatment.
























/kupiti-suhagra-100-mg-4-cena-dostavka-v-ukraini-74-228x228.jpg)




















/kupiti-tadacip-4-cena-dostavka-v-ukraini-138-228x228.jpg)






